Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 09, 2023 07:50 ET | Source: Reneo Pharmaceuticals, Inc.

Reneo Pharmaceuticals Announces Last Patient Last Visit in the Pivotal STRIDE Study of Mavodelpar in Primary Mitochondrial Myopathies (PMM)

IRVINE, Calif., Oct. 09, 2023 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (Nasdaq: RPHM), a clinical-stage pharmaceutical company focused on the development and commercialization of therapies...
October 06, 2023 08:30 ET | Source: Reneo Pharmaceuticals, Inc.

Reneo Pharmaceuticals to Participate in the Jefferies Biotech CNS/Neuro Summit

IRVINE, Calif., Oct. 06, 2023 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (Nasdaq: RPHM), a clinical stage pharmaceutical company focused on the development and commercialization of therapies...
August 29, 2023 07:35 ET | Source: Reneo Pharmaceuticals, Inc.

Reneo Pharmaceuticals to Participate in Upcoming Investor Conferences

IRVINE, Calif., Aug. 29, 2023 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM), a clinical stage pharmaceutical company focused on the development and commercialization of therapies...
August 10, 2023 07:35 ET | Source: Reneo Pharmaceuticals, Inc.

Reneo Pharmaceuticals Reports Second Quarter 2023 Financial Results

IRVINE, Calif., Aug. 10, 2023 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (Nasdaq: RPHM), a clinical-stage pharmaceutical company focused on the development and commercialization of therapies...
June 30, 2023 08:25 ET | Source: Reneo Pharmaceuticals, Inc.

Reneo Pharmaceuticals to Participate in SVB Securities Therapeutics Forum

IRVINE, Calif., June 30, 2023 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM), a clinical stage pharmaceutical company focused on the development and commercialization of therapies...
June 26, 2023 08:25 ET | Source: Reneo Pharmaceuticals, Inc.

Reneo Pharmaceuticals Added to Russell 2000® and Russell 3000® Indices

IRVINE, Calif., June 26, 2023 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (Nasdaq: RPHM), a clinical-stage pharmaceutical company focused on the development and commercialization of therapies...
June 15, 2023 12:44 ET | Source: Reneo Pharmaceuticals, Inc.

Reneo Pharmaceuticals Announces Presentation and Posters at Mitochondrial Medicine Symposium 2023

IRVINE, Calif., June 15, 2023 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM), a clinical stage pharmaceutical company focused on the development and commercialization of therapies...
May 31, 2023 10:38 ET | Source: Reneo Pharmaceuticals, Inc.

Update -- Reneo Pharmaceuticals to Participate at the Jefferies Healthcare Conference

IRVINE, Calif., May 31, 2023 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM), a clinical stage pharmaceutical company focused on the development and commercialization of therapies for...
May 31, 2023 08:00 ET | Source: Reneo Pharmaceuticals, Inc.

Reneo Pharmaceuticals to Participate at the Jefferies Healthcare Conference

IRVINE, Calif., May 31, 2023 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM), a clinical stage pharmaceutical company focused on the development and commercialization of therapies for...
May 11, 2023 07:45 ET | Source: Reneo Pharmaceuticals, Inc.

Reneo Pharmaceuticals Reports First Quarter 2023 Financial Results

Completed enrollment of the pivotal STRIDE study; topline results anticipated 4Q 2023Raised $68.3 million in gross proceeds from a concurrent public offering and private placement IRVINE, Calif.,...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right